Advertisement Roxane launches acarbose tablets - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Roxane launches acarbose tablets

Roxane Laboratories has announced the approval of its abbreviated new drug application for acarbose tablets, 25mg, 50mg, and 100mg.

The product is available in bottles of 100 tablets for all strengths as well as unit dose blisters for the 50mg strength and is available for immediate shipment to wholesalers and pharmacies nationwide.

Roxane’s acarbose tablets are AB rated to Precose (acarbose), which is indicated for the treatment of type 2 diabetes.